Copyright
©The Author(s) 2022.
World J Gastroenterol. Dec 21, 2022; 28(47): 6702-6715
Published online Dec 21, 2022. doi: 10.3748/wjg.v28.i47.6702
Published online Dec 21, 2022. doi: 10.3748/wjg.v28.i47.6702
Figure 5 Pathophysiology of functional dyspepsia and possible mechanisms of the effects of LG21 treatment.
SIBO: Small intestinal bacterial overgrowth; LPS: Lipopolysaccharide.
- Citation: Koga Y. Microbiota in the stomach and application of probiotics to gastroduodenal diseases. World J Gastroenterol 2022; 28(47): 6702-6715
- URL: https://www.wjgnet.com/1007-9327/full/v28/i47/6702.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i47.6702